| Depot-medroxyprogesterone acetate (DMPA) and cancer: memorandum from a WHO meeting. | |
| | |
MedLine Citation:
|
PMID: 2945666 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A review of all available data including those from the WHO Collaborative Study of Neoplasia and Steroid Contraceptives has shown no increased risk of cancers of the breast, endometrium, ovary or liver in women using depot-medroxyprogesterone acetate (DMPA). The issue of a causal association between DMPA use and cervical cancer is as yet unresolved and will require the accumulation of additional data. To date, in the WHO study only a small number of women have used DMPA for prolonged periods or have had a long interval since first use. Information on cancer risk in these women can only be gained by continuing the present study or by initiating additional studies focused on these specific topics. |
| | |
Authors:
|
- |
Related Documents
:
|
3872736 - Current status of amantadine and rimantadine as anti-influenza-a agents: memorandum fro... 19309366 - Footprints of the eadv: a meeting report from the 17th congress of the european academy... 14608766 - How to make staff meetings more enjoyable and productive. 20074026 - Searching for the boundaries: unlimited expansion of ubiquitin and ubiquitin-like signa... 20683926 - Practical guidelines addressing ethical issues pertaining to the curation of human locu... 2050496 - The maternal erotic countertransference. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Bulletin of the World Health Organization Volume: 64 ISSN: 0042-9686 ISO Abbreviation: Bull. World Health Organ. Publication Date: 1986 |
Date Detail:
|
Created Date: 1986-11-24 Completed Date: 1986-11-24 Revised Date: 2010-10-26 |
Medline Journal Info:
|
Nlm Unique ID: 7507052 Medline TA: Bull World Health Organ Country: SWITZERLAND |
Other Details:
|
Languages: eng Pagination: 375-82 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Female Humans Medroxyprogesterone / adverse effects, analogs & derivatives* Medroxyprogesterone Acetate Neoplasms / etiology* Risk |
| Chemical | |
Reg. No./Substance:
|
520-85-4/Medroxyprogesterone; 71-58-9/Medroxyprogesterone Acetate |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Clinical disorders of the red cell membrane skeleton.
Next Document: Beneficial actions of thromboxane receptor antagonism in hemorrhagic shock.